BACKGROUND: We previously showed that parenteral nutrition (PN) compared with formula feeding results in hepatic insulin resistance and steatosis in neonatal pigs. The current aim was to test whether the route of feeding (intravenous [IV] vs enteral) rather than other feeding modalities (diet, pattern) had contributed to the outcome. METHODS: Neonatal pigs were fed enterally or parenterally for 14 days with 1 of 4 feeding modalities as follows: (1) enteral polymeric formula intermittently (FORM), (2) enteral elemental diet (ED) intermittently (IEN), (3) enteral ED continuously (CEN), and (4) parenteral ED continuously (PN). Subgroups of pigs underwent IV glucose tolerance tests (IVGTT) and hyperinsulinemic-euglycemic clamps (CLAMP). Following CLAMP, pigs were euthanized and tissues collected for further analysis. RESULTS: Insulin secretion during IVGTT was significantly higher and glucose infusion rates during CLAMP were lower in CEN and PN than in FORM and IEN. Endogenous glucose production rate was suppressed to zero in all groups during CLAMP. In the fed state, plasma glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide (GLP)-1, and GLP-2 were different between feeding modalities. Insulin receptor phosphorylation in liver and muscle was decreased in IEN, CEN, and PN compared with FORM. Liver weight was highest in PN. Steatosis and myeloperoxidase (MPO) activity tended to be highest in PN and CEN. Enterally fed groups had higher plasma GLP-2 and jejunum weight compared with PN. CONCLUSIONS: PN and enteral nutrition (EN) when given continuously as an elemental diet reduces insulin sensitivity and the secretion of key gut incretins. The intermittent vs continuous pattern of EN produced the optimal effect on metabolic function.
BACKGROUND: We previously showed that parenteral nutrition (PN) compared with formula feeding results in hepatic insulin resistance and steatosis in neonatal pigs. The current aim was to test whether the route of feeding (intravenous [IV] vs enteral) rather than other feeding modalities (diet, pattern) had contributed to the outcome. METHODS: Neonatal pigs were fed enterally or parenterally for 14 days with 1 of 4 feeding modalities as follows: (1) enteral polymeric formula intermittently (FORM), (2) enteral elemental diet (ED) intermittently (IEN), (3) enteral ED continuously (CEN), and (4) parenteral ED continuously (PN). Subgroups of pigs underwent IV glucose tolerance tests (IVGTT) and hyperinsulinemic-euglycemic clamps (CLAMP). Following CLAMP, pigs were euthanized and tissues collected for further analysis. RESULTS:Insulin secretion during IVGTT was significantly higher and glucose infusion rates during CLAMP were lower in CEN and PN than in FORM and IEN. Endogenous glucose production rate was suppressed to zero in all groups during CLAMP. In the fed state, plasma glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide (GLP)-1, and GLP-2 were different between feeding modalities. Insulin receptor phosphorylation in liver and muscle was decreased in IEN, CEN, and PN compared with FORM. Liver weight was highest in PN. Steatosis and myeloperoxidase (MPO) activity tended to be highest in PN and CEN. Enterally fed groups had higher plasma GLP-2 and jejunum weight compared with PN. CONCLUSIONS: PN and enteral nutrition (EN) when given continuously as an elemental diet reduces insulin sensitivity and the secretion of key gut incretins. The intermittent vs continuous pattern of EN produced the optimal effect on metabolic function.
Authors: Norbert Stefan; Jürgen Machann; Fritz Schick; Claus D Claussen; Claus Thamer; Andreas Fritsche; Hans-Ulrich Häring Journal: Horm Res Date: 2006-01-20
Authors: Lawrence Schook; Craig Beattie; Jonathan Beever; Sharon Donovan; Russell Jamison; Federico Zuckermann; Steven Niemi; Max Rothschild; Mark Rutherford; Douglas Smith Journal: Anim Biotechnol Date: 2005 Impact factor: 2.282
Authors: Kathryn M S Johnson; Dale S Edgerton; Tiffany Rodewald; Melanie Scott; Ben Farmer; Doss Neal; Alan D Cherrington Journal: Am J Physiol Endocrinol Metab Date: 2007-08-07 Impact factor: 4.310
Authors: Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-10-23 Impact factor: 4.052
Authors: Gregory Guthrie; Madhulika Kulkarni; Hester Vlaardingerbroek; Barbara Stoll; Kenneth Ng; Camilia Martin; John Belmont; Darryl Hadsell; William Heird; Christopher B Newgard; Oluyinka Olutoye; Johannes van Goudoever; Charlotte Lauridsen; Xingxuan He; Edward H Schuchman; Douglas Burrin Journal: J Lipid Res Date: 2016-07-29 Impact factor: 5.922
Authors: Tiffany L Molina; Barbara Stoll; Mahmoud Mohammad; Carrie A Mohila; Lee Call; Liwei Cui; Gregory Guthrie; Dennis Kunichoff; Sen Lin; Rebecca Welch-Jernigan; Jon Nielsen; Muralidhar Premkumar; Jason Robinson; Victoria Smith; Haley Teets; Karina Obelitz-Ryom; Joseph Hagan; Stephanie Cruz; Patricio Lau; Maurice Puyau; Roman Shypailo; Rodrigo Manjarin; Nancy Butte; Zhengfeng Fang; Oluyinka Olutoye; Thomas Thymann; Per Sangild; Douglas Burrin Journal: Brain Behav Immun Date: 2019-04-24 Impact factor: 7.217
Authors: Jane K Naberhuis; Agus Suryawan; Hanh V Nguyen; Adriana Hernandez-Garcia; Stephanie M Cruz; Patricio E Lau; Oluyinka O Olutoye; Barbara Stoll; Douglas G Burrin; Marta L Fiorotto; Teresa A Davis Journal: Am J Physiol Endocrinol Metab Date: 2019-09-10 Impact factor: 4.310
Authors: Joseph F Pierre; Joshua C Neuman; Allison L Brill; Harpreet K Brar; Mary F Thompson; Mark T Cadena; Kelsey M Connors; Rebecca A Busch; Aaron F Heneghan; Candace M Cham; Elaina K Jones; Carly R Kibbe; Dawn B Davis; Guy E Groblewski; Kenneth A Kudsk; Michelle E Kimple Journal: Am J Physiol Gastrointest Liver Physiol Date: 2015-07-16 Impact factor: 4.052
Authors: Juan C Marini; Barbara Stoll; Inka Cajo Didelija; Douglas G Burrin Journal: Am J Physiol Endocrinol Metab Date: 2012-10-16 Impact factor: 4.310
Authors: Hester Vlaardingerbroek; Kenneth Ng; Barbara Stoll; Nancy Benight; Shaji Chacko; Leo A J Kluijtmans; Wim Kulik; E James Squires; Oluyinka Olutoye; Deborah Schady; Milton L Finegold; Johannes B van Goudoever; Douglas G Burrin Journal: J Lipid Res Date: 2014-01-29 Impact factor: 5.922